Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both TetraHydroCannabinol (THC) and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool.


TSXV:PCLO - Post by User

Bullboard Posts
Post by nickthebullon Jan 22, 2019 8:48am
43 Views
Post# 29263410

Management is key

Management is keyIf any of you still doubty the ability of the management to reach trade agreements, take a closer look at their previous achievements. 


Nobody at that time wanted anything to do with China. Big difference now with a global marijuana acceptance trend already in motion.

''Mr. Langelier was president of Eastern Asia with Philip Morris Asia Limited in Hong Kong from 2005-07, responsible for annual revenue of $5.7 billion and 3,500 employees in Japan (PMI’s most profitable market), Australia, New Zealand, South Korea and Greater China (PRC, Hong Kong and Taiwan). He participated in the final negotiations with the Chinese monopoly that resulted in a favorable joint venture agreement for international commercialization of Chinese trademarks and a license agreement for Marlboro in China.''

Bullboard Posts